Biostage appoints Jerry He as Chairman and CEO; David Green remains on Board

Harvard Apparatus Regenerative Technology, Inc.

Jerry He appointed Chairman and CEO effective March 1, 2023, replacing David Green.
David Green to remain on Board and support transition.
He previously served as EVP of Bright Scholar Education and CEO of Noah Education.
Biostage is a clinical-stage biotech developing regenerative medicine for esophageal cancer.
Company plans to begin FDA-approved clinical trial for esophageal cancer.

item 1.01 item 8.01 item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

David Green

Chairman and Chief Executive Officer

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2023-03-01
Successor: Junli (Jerry) He
Filed: March 7, 2023, 6:59 PM ET

in replacement of David Green in such roles.

Role change

Junli (Jerry) He

Chairman and Chief Executive Officer

HRGN · Harvard Apparatus Regenerative Technology, Inc.

Effective: 2023-03-01
Filed: March 7, 2023, 6:59 PM ET

Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

David Green resigned as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..

Action: resigned
Role: Chairman and Chief Executive Officer

Exact text from the filing

in replacement of David Green in such roles.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Junli (Jerry) He was appointed as Chairman and Chief Executive Officer at Harvard Apparatus Regenerative Technology, Inc..

Action: appointed
Role: Chairman and Chief Executive Officer

Exact text from the filing

Junli (Jerry) He, was appointed Chairman and Chief Executive Officer of the Company, in replacement of David Green in such roles.

View on SEC.gov

Harvard Apparatus Regenerative Technology, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-006927

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.